PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Menghua Xia

University of Science and Technology of China

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 10, 2026 · JOURNAL ARTICLE

Prognostic disparities between radioactive iodine-refractory and non-refractory DTC patients: a cohort study on survival rates and independent risk factors

Future Oncology

Retrospective cohort study with clear stratification and identified prognostic factors in radioiodine-refractory DTC, but limited by single-centre design, modest sample size, and surrogate endpoint assessment in the non-refractory group.

PromisingThyroid Cancer Diagnosis and Treatment Menghua Xia Liqin Bi

Reported

Sample size146

RAIR group size56

NRAIR group size90

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support